Login / Signup

Efficacy of azole therapy for tegumentary leishmaniasis: A systematic review and meta-analysis.

Endi Lanza GalvãoAna RabelloGláucia Fernandes Cota
Published in: PloS one (2017)
Available evidence suggests that fluconazole, ketoconazole and itraconazole have similar and modest efficacy rates for tegumentary leishmaniasis treatment. There is insufficient evidence to support the exclusive use of azole therapy as a single agent for leishmaniasis treatment.
Keyphrases
  • candida albicans
  • bone marrow
  • replacement therapy
  • mesenchymal stem cells
  • cell therapy
  • smoking cessation